Glenn Rockman and his colleagues founded Adjuvant Capital in 2018 to build an investment firm that champions the most promising life science technologies for high-burden and neglected public health challenges. Prior to Adjuvant, Glenn launched and then co-managed the Global Health Investment Fund (GHIF), which was created by the Bill & Melinda Gates Foundation to demonstrate that historically overlooked diseases can present compelling double-bottom-line investment opportunities. Prior to his roles at GHIF and now Adjuvant, Glenn spent more than a decade as an investment banker at J.P. Morgan, where his practice focused on serving the financing needs of research institutions, charitable foundations, universities, and other non-profit organizations. He earned an AB in public policy from the Woodrow Wilson School of Public & International Affairs at Princeton University.